Merck
MRK
#64
Rank
โ‚ฌ208.10 B
Marketcap
83,32ย โ‚ฌ
Share price
-2.06%
Change (1 day)
-12.99%
Change (1 year)

Revenue for Merck (MRK)

Revenue in 2025 (TTM): โ‚ฌ57.49 Billion

According to Merck's latest financial reports the company's current revenue (TTM ) is โ‚ฌ55.23 Billion. In 2024 the company made a revenue of โ‚ฌ61.66 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ54.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Merck from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ57.49 B-6.76%
2024 โ‚ฌ61.66 B13.4%
2023 โ‚ฌ54.37 B-1.61%
2022 โ‚ฌ55.26 B28.51%
2021 โ‚ฌ43.00 B17.93%
2020 โ‚ฌ36.46 B-12.79%
2019 โ‚ฌ41.81 B13.1%
2018 โ‚ฌ36.97 B10.56%
2017 โ‚ฌ33.43 B-11.64%
2016 โ‚ฌ37.84 B4.76%
2015 โ‚ฌ36.12 B4.02%
2014 โ‚ฌ34.72 B8.92%
2013 โ‚ฌ31.88 B-10.77%
2012 โ‚ฌ35.73 B-3.42%
2011 โ‚ฌ36.99 B7.01%
2010 โ‚ฌ34.57 B80.59%
2009 โ‚ฌ19.14 B12.22%
2008 โ‚ฌ17.06 B2.94%
2007 โ‚ฌ16.57 B-3.39%
2006 โ‚ฌ17.15 B-7.68%
2005 โ‚ฌ18.58 B9.89%
2004 โ‚ฌ16.91 B-5.32%
2003 โ‚ฌ17.86 B-57.88%
2002 โ‚ฌ42.40 B-21.52%
2001 โ‚ฌ54.02 B26.1%
2000 โ‚ฌ42.84 B31.79%
1999 โ‚ฌ32.51 B43.43%
1998 โ‚ฌ22.66 B13.8%
1997 โ‚ฌ19.91 B19.21%
1996 โ‚ฌ16.70 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ53.98 B-2.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.23 B 43.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.09 B-7.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.30 B-25.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.86 B-26.01%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ36.41 B-34.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.42 B-73.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
โ‚ฌ48.47 B-12.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
โ‚ฌ37.70 B-31.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.93 B-44.00%๐Ÿ‡บ๐Ÿ‡ธ USA